Mineralocorticoids and cardiac fibrosis: The decade in review

Clinical and Experimental Pharmacology and Physiology

Volumn 28, Issue 12, 2001, Pages 1002-1006

  Funder, John ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

11 hydroxysteroid dehydrogenase; Aldosterone; Hypertension; Mineralocorticoid receptors; Salt; Sodium hydrogen exchange

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE1; 11BETA HYDROXYSTEROID DEHYDROGENASE2; ALDOSTERONE; AMILORIDE; ANGIOTENSIN 1 RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CANRENOATE POTASSIUM; CORTICOSTERONE; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; OXPRENOATE POTASSIUM; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SODIUM CHLORIDE; SPIRONOLACTONE; UNCLASSIFIED DRUG;

BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HORMONE SYNTHESIS; HOSPITALIZATION; HUMAN; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SMOOTH MUSCLE FIBER; VASCULITIS;

ALDOSTERONE; ANIMALS; CLINICAL TRIALS; EPITHELIUM; FIBROSIS; HUMANS; MINERALOCORTICOIDS; MYOCARDIUM; SODIUM CHLORIDE;

EID: 0035687851     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2001.03586.x     Document Type: Conference Paper

References (27)

1. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis
2. Mineralocorticoids, hypertension, and cardiac fibrosis
3. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension
4. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone
5. Anti-fibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension
6. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt induced cardiac fibrosis
7. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
8. Aldosterone and cardiac fibrosis: In vitro studies
9. 1 receptor subtype as a cardiac target of aldosterone: Role in aldosterone-salt-induced fibrosis
10. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension
11. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats
12. High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes
13. Prerequisite for aldosterone action. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase in human heart
14. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: In vivo binding studies
15. Role of 11beta-hydroxysteroid dehydrogenase on nongenomic aldosterone effects in human arteries
16. Aldosterone-receptor deficiency in pseudohypoaldosteronism
17. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
18. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: Insights from the Randomized Aldactone Evaluation Study (RALES)
19. Aldosterone production is activated in failing ventricle in humans
20. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure
21. Type 1 aldosterone synthase deficiency presenting in a middle-aged man
22. Epithelial sodium channel regulated by aldosterone-induced protein sgk
23. The sgk, an aldosterone-induced gene in mineralocorticoid target cells, regulates the epithelial sodium channel
24. The serum- and gluco-corticoid-induced kinase is a physiological mediator of aldosterone action
25. Rapid upregulation of serum and glucocorticoid-regulated kinase (sgk) gene expression by corticosteroids in vivo
26. Experimental cardiac fibrosis: Differential time course of responses to mineralocorticoid-salt administration
27. Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries